Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAOLA: Pasireotide LAR in Acromegaly
NCT01137682Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2010
- Primary completion
- Jan 2013
- Modality
- Peptides, Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of pasireotide LAR in acromegaly, sponsored by Novartis. Started Jul 2010; status: completed.
02
Drugs
pasireotide LAR
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT01137682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137682.